Angene Chemical
Draw
|
Currency :
Home Products

AG00373W

639089-54-6 | N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide

Chemical structure of N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide, CAS 639089-54-6
AG00373W
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 639089-54-6
Catalog Number AG00373W(AGN-PC-0TAHLJ)
Chemical Name N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide
IUPAC Name N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide
InChI InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)
InChI Key GCIKSSRWRFVXBI-UHFFFAOYSA-N
MDL Number MFCD13185152
Molecular Formula C23H28N8OS
Molecular Weight 464.5864
NSC Number 745967
SMILES CN1CCN(CC1)C1=NC(=NC(=C1)NC1=NNC(=C1)C)SC1=CC=C(C=C1)NC(=O)C1CC1
UNII 234335M86K
Synonyms
cyclopropane carboxylic acid(4-(4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-ylsulfanyl)phenyl)amide, MK-0457, Tozasertib, VE 465, VE-465, VX-680, VX680, Tozasertib, 639089-54-6, VX-680, MK-0457, MK 0457, VX 680, VX680, UNII-234335M86K, VX-68, MK-045, VX-680 (MK-0457,Tozasertib), L-001281814, CHEMBL572878, N-(4-(4-(3-methyl-1H-pyrazol-5-ylamino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide, N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide, GCIKSSRWRFVXBI-UHFFFAOYSA-N, Tozasertib(MK-0457,VX-680), N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide, VX6, VX-680(MK-0457), AK174787, 234335M86K, Cyclopropanecarboxamide,N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-, Cyclopropanecarboxylic Acid {4-[4-(4-Methyl-Piperazin-1-Yl)-6-(5-Methyl-2h-Pyrazol-3-Ylamino)-Pyrimidin-2-Ylsulfanyl]-Phenyl}-Amide, N-(4-((4-((5-methyl-1H-pyrazol-3-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide, N-[4-({4-[(3-methyl-1H-pyrazol-5-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide, Tozasertib (USAN), Tozasertib [USAN:INN], VX-680 (MK-0457, Tozasertib), Kinome_3803, PubChem22451, 2f4j, AC1NUV5F, Cyclopropanecarboxylic acid N-(4-((4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-yl)sulfanyl)phenyl)amide, MLS001065920, SCHEMBL614528, GTPL5718, BDBM13534, CHEBI:91336, CTK8E8460, KS-00000XGU, DTXSID10213609, QCR-107, SYN1092, BCPP000017, HMS2043N07, HMS2198F22, HMS3244O19, HMS3244O20, HMS3244P19, HMS3265C21, HMS3265C22, HMS3265D21, HMS3265D22, HMS3654I11, ACT03970, AOB87770, BCP01859, EX-A2179, ZINC3820040, ABP000120, AN-505, BDBM50004205, MFCD13185152, NSC745967, RS0018, s1048, VX-680 (MK-0457 Tozasertib), VX-680; Tozasertib; MK-0457, AKOS015902930, API0015204, CS-0007, KIN0001375, NSC-745967, SB19302, Tozasertib (VX-680, MK-0457), VX-680 (Tozasertib, MK-0457), VX-680 - MK0457 - Tozasertib, NCGC00168110-01, NCGC00168110-02, NCGC00168110-05, 936915-58-1, AM808097, AS-18632, Cyclopropane carboxylic acid{4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2-ylsulphanyl]-phenyl}-amide, HY-10161, SMR000486395, VX-680 (MK-0457), AB0007989, FT-0652724, SW212828-2, W9901, EC-000.2365, A19417, D08279, W-5565, 089V546, I14-1964, J-523024, BRD-K59369769-001-02-1, BRD-K59369769-001-09-6, BRD-K59369769-001-12-0, BRD-K59369769-001-14-6, BRD-K87947369-001-01-6, cyclopropane carboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2h-pyrazol-3-ylamino)-pyrimidin-2-ylsulphanyl]-phenyl}-amide, cyclopropane carboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2ylsulphanyl]-phenyl}-amide, Cyclopropanecarboxamide, N-(4-((4-(4-methyl-1-piperazinyl)-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)thio)phenyl)-, Cyclopropanecarboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-1H-pyrazol-3-ylamino)-pyrimidin-2, N-(4-((4-((3-methyl-1H-pyrazol-5-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide, N-(4-((4-(4-Methylpiperazin-1-yl)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide, N-?[4-?[[4-?(4-?methyl-?1-?piperazinyl)-?6-?[(5-?methyl-?1H-?pyrazol-?3-?yl)amino]-?2-?pyrimidinyl]thio]phenyl]-?cyclopropanecarboxamide, N-[4-({4-(4-methylpiperazin-1-yl)-6-[(3-methyl-1H-pyrazol-5-yl)amino]pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide, N-[4-({4-[(5-methyl-1H-pyrazol-3-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide, N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-cyclopropanecarboxamide, N-[4-[[4-(4-methylpiperazino)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]thio]phenyl]cyclopropanecarboxamide, Tozasertib [USAN], D02XNW, -ylsulfanyl]-phenyl}-amide, C23H28N8OS, cc-202, C23-H28-N8-O-S, VE 465, VE-465, ACN-040198, CID5494449, A4111, MK-0457, Tozasertib, VX680, VX-680, A10981, C484810, cyclopropane carboxylic acid(4-(4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-ylsulfanyl)phenyl)amide, Cyclopropanecarboxamide, N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited